Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) / CORREALE P; TAGLIAFERRI P; FIORAVANTI A; DEL VECCHIO MT; REMONDO C; MONTAGNANI; F; ROTUNDO MS; GINANNESCHI C; MARTELLUCCI I; FRANCINI E; CUSI MG; TASSONE P; FRANCINI G. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 14(13)(2008), pp. 4192-4199.



Titolo: Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)
Autori: 
TAGLIAFERRI, Piersandro
TASSONE, PIERFRANCESCO
mostra contributor esterni 
Data di pubblicazione: 2008
Rivista: 
CLINICAL CANCER RESEARCH  
Handle: http://hdl.handle.net/20.500.12317/7941
Appare nelle tipologie:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/20.500.12317/7941
  • Citazioni
  • PubMed Central ND
  • Scopus ND

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021